The linked piece looks at what adding a GLP-1 receptor agonist could mean for the kidneys of patients already taking lithium.
Recap by typeshit. Post by Sandeep Saluja on X.
The Washington Post looks at why so many users report shedding, a problem now nicknamed "Ozempic hair," and what new research suggests about the cause.
She says GLP-1 drugs slow how fast the stomach empties. That can let stomach contents reach the lungs during sedation, even after fasting.
The endocrinologist cautions that an interesting effect seen in animals does not mean a compound is suitable for human use.
The account calls the up to 28% weight loss impressive but says only about half of participants finished, citing nausea, constipation and skin sensitivity.
A short reaction clip from a doctor who treats obesity, weighing in on whether children with obesity should be prescribed GLP-1s.
The study will test whether people on weekly semaglutide or tirzepatide for weight can switch to a monthly treatment. Recruitment opens soon.
Loading…